Drug intelligence / Profile preview

Equate Eye Allergy Relief Drops

Development stage
Unknown
Lead developer
Walmart
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Equate Eye Allergy Relief Drops is an over-the-counter **ophthalmic combination product** marketed under Walmart's Equate private-label brand for temporary relief of **allergic conjunctival symptoms**, particularly eye **itching and redness** triggered by allergens such as pollen, ragweed, grass, animal hair, and dander. The sterile ophthalmic solution contains two **small-molecule** active ingredients: **naphazoline hydrochloride 0.02675%**, an alpha-adrenergic sympathomimetic vasoconstrictor that reduces conjunctival hyperemia by constricting superficial ocular blood vessels, and **pheniramine maleate 0.315%**, a first-generation antihistamine that blocks histamine signaling to relieve allergic itching. The product is positioned as comparable to Opcon-A and is supplied in 0.5 fl oz bottles for ophthalmic administration.

Brand names
Equate Eye Allergy Relief Drops
Other names
naphazoline hydrochloride + pheniramine maleate ophthalmic solutionequate eye allergy reliefcomparable to Opcon-A
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Equate Eye Allergy Relief Drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equate Eye Allergy Relief Drops.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call